Clinical Trial Update: Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maralixibat in biliary atresia patients after Kasai procedure has completed; results were posted on 2025-02-17.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Atresia

Drugs mentioned

• Maralixibat (maralixibat)

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Biliary Atresia | Phase 2 | Status: COMPLETED | Results posted: 2025-02-17